Antigen-presenting cell surfaces and depot at injection site

The concept of antigen-presenting cell (APC) surfaces and the depot at the injection site refers to the localized environment created by vaccine formulations to enhance the immune response (He et al., 2015, Vaccines). The 'depot effect' is a classical pharmacological mechanism where adjuvants, such as aluminum salts or oil-in-water emulsions, sequester the vaccine antigen at the site of administration (Ghimire, 2015, Frontiers in Immunology). This sequestration prevents rapid systemic clearance and ensures a slow, sustained release of the antigen over time, which facilitates the continuous recruitment of professional APCs like dendritic cells to the site (Leroux-Roels, 2010, Vaccine). Once recruited, these APCs internalize the antigen and present it on their surfaces via Major Histocompatibility Complex (MHC) molecules to initiate adaptive immunity (Reed et al., 2013, Nature Medicine). This interaction is the fundamental step in activating T-lymphocytes and orchestrating a robust immune memory. While not a single molecular receptor, this site is the functional focus for adjuvant engineering to improve vaccine efficacy against infectious diseases and in cancer immunotherapy.

Other names

Depot effectInjection site depotAntigen depotAPC-antigen interfaceVaccine depot

The mechanism involves the sequestration of antigens at the injection site to provide a slow, sustained release (depot effect), alongside the recruitment and activation of antigen-presenting cells (APCs) through local inflammatory signaling (Ghimire, 2015, Frontiers in Immunology).